Pulmonology

The findings of these 2 new studies are in contrast to those of previous trials, which had conflicting results.

The rate of events was higher in patients with late‐onset asthma-but not in those with early‐onset asthma-than in nonasthmatics.

Results of the NIDA teen survey sound promising but other experts maintain that even inhaling flavored vapor is a gateway to tobacco.

E-cigarettes more than replaced the tobacco variety--plus more good news/bad news on trends in teen behavior.

Using music in medicine is an ancient practice. Here we review recent research efforts to better understand and apply music’s healing powers.

Vitamins C and E, in particular, have a beneficial effect on COPD risk and lung function in men, a new study found.

Cigarette smoking has declined but remains a leading cause of illness and death in the US. If there is anything you don’t know about the current state of smoking, you’ll find it in these slides.

The best asthma care is not good enough if the patient is nonadherent. Applied "humanomics" as an approach to chronic care was discussed this week at CHEST 2015.

Exacerbations of COPD often complicate CV outcomes. Two studies presented at CHEST 2015 looked at ways to refine risk factors for CV decline.

Severe refractory asthma resists conventional therapies, but a roster of new biologics, discussed at CHEST 2015 in Montreal, may soon offer relief.

Here, during Respiratory Care Week, studies address safety concerns with new opioid use, relationships between PTSD and COPD, and a new smartphone app for better patient compliance.

Study results revealed at CHEST 2015 showed use of FeNO to assess inflammation led family physicians to change steroid dose in 50% of asthma patients.

ACOS is often first suspected in the primary care setting. Experts at CHEST 2015 reviewed the syndrome, who is at risk, and treatment challenges.

The CDC estimates that 21% of people with asthma smoke cigarettes. These patients tend to be resistant to common asthma treatment. What are the options?

This liquid instillation approach may lead to more effective treatment for a variety of lung diseases, including cystic fibrosis, COPD, bronchopneumonia, and lung cancer.

Once again, the USPSTF finds no net benefit to screening asymptomatic persons for COPD. Draft recommendation is available for comment.

Reductions in mortality, need for life support, hospital stays, and other measures should win this drug class serious consideration, study authors say.

Lethal prostate cancer is less-not more-likely to develop in patients with asthma. The Health Professionals Follow-up Study answers key questions about why.

Targeting these risk factors with adjunctive therapy may help improve outcomes, say authors of a new study.

A new CDC study also found that older adults are more likely to be hospitalized for a severe respiratory virus than those aged 18 to 49 years.

Infections with pneumonia send a substantial number of older adults to the hospital, much more than younger adults. Researchers are calling for new rapid diagnostic tests.

The GOLD criteria for COPD assessment have not lived up to their promise. Internationally agreed standards seem to be the real deal.

Aging and comorbidities make asthma management in the elderly much more difficult than in younger people. Get a quick look here at what to watch out for.

Undiagnosed lung disease in smokers, the impact of guidelines for community-acquired pneumonia in children, and climate change and asthma attacks make headlines in the respiratory news.

Exacerbations in asthma are common long after patients receive step down medications, and other respiratory disease news.